Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Non-Current Assets (2015 - 2026)

Immuron (IMRN) posted Non-Current Assets of $192721.0 for Q3 2026, up 68.14% on a QoQ basis from $114616.0 in Q4 2025, and up 16714.49% year-over-year from N/an in Q3 2025.

Analysis

Immuron (IMRN) Non-Current Assets (2015 - 2026) Analysis & Trends

Immuron has reported Non-Current Assets for 12 years, with the latest figure at $192721.0 in Q3 2026.

  • On a quarterly basis, Non-Current Assets rose 16714.49% year-over-year to $192721.0 in Q3 2026; TTM through Aug 2026 was $381887.1, a 123.99% increase from a year earlier, with the FY2026 full-year figure at $192721.0, up 16714.49% from the prior year.
  • Non-Current Assets was $192721.0 for Q3 2026 at Immuron, up from $114616.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $1.1 million in Q2 2023, with the low at -$16.5 million in Q3 2022.
  • Average Non-Current Assets over 5 years is -$4.1 million, with a median of $3317.2 recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Assets tumbled 86.48% in 2025, then jumped 16714.49% in 2026.
  • Over 5 years, Non-Current Assets stood at -$15.4 million in 2022, then advanced by 14.57% to -$13.2 million in 2023, then jumped by 87.29% to -$1.7 million in 2024, then jumped by 106.86% to $114616.0 in 2025, then surged by 68.14% to $192721.0 in 2026.
  • The last three Non-Current Assets figures came in at $192721.0 (Q3 2026), $114616.0 (Q4 2025), and $1146.2 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.96 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 564.41 Mn
10 Immuron 10.28 Mn 1.26 Mn - 192,721.00
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 192,721.00
Dec 31, 2025 114,616.00
Sep 2, 2025 1,146.16
Jun 30, 2025 73,403.89
Dec 31, 2024 -1.67 Mn
Sep 9, 2024 5,488.15
Jun 30, 2024 542,793.65
Dec 31, 2023 -13.16 Mn
Sep 28, 2023 -13.38 Mn
Aug 30, 2023 -204,093.37
Jun 30, 2023 1.06 Mn
Dec 31, 2022 -15.40 Mn
Aug 31, 2022 -16.46 Mn
Jun 30, 2022 847,826.76
Dec 31, 2021 -18.67 Mn
Sep 30, 2021 -18.94 Mn
Jun 30, 2021 1.00 Mn
Dec 31, 2020 2.80 Mn
Sep 1, 2020 1.61 Mn
Jun 30, 2020 1.18 Mn